Skip to content
NKCELLThe NK guide

The biology

What Does CD16 Do on NK Cells?

CD16 is an antibody-facing receptor on natural killer cells, not a lone kill switch. The useful distinction is between a receptor that can engage antibody-coated targets and lab markers that identify NK subsets.

CD16 is the antibody-facing receptor on a natural killer (NK) cell, not a standalone kill switch. A concrete way to separate the ideas: CD16 is the docking site that can engage a target already coated with antibody; CD56 is a surface marker used in the lab to help identify NK cells and their subsets. They are often read together, but they answer different questions.

A docking site is not an ID badge

An NK cell is an immune cell that can respond to stressed or infected cells. CD16 sits on its surface and belongs to the Fc-receptor family. In plain terms, an Fc receptor is a surface protein that reads the antibody end of an immune response—the Fc region, or tail, of an antibody. The explanatory inference is that CD16 gives an NK cell a way to grip a target that antibodies have already marked. That makes CD16 more like a connector than a general-purpose weapon: the receptor recognizes the antibody layer, and the NK cell's response depends on what else is happening around it.

CD56 is different in kind. It is a marker used to identify NK cells and to separate subsets in the lab. Mayo Clinic Laboratories' description of its NK/NKT subset test uses CD3 negativity and CD16/CD56 markers to identify and count NK subsets in blood. The same page states that the test is not intended for diagnosing or classifying NK malignancy. That is a statement about the test's intended use, not a claim that CD16 has no biological role.

CD16 can sit inside a subset label

A cell can be positive for CD16 and still not be doing one fixed job. A human-cell study on CD57 found that, within the CD56dimCD16+ NK-cell subset, CD57 marks a functionally distinct mature population. The same body of work supports a picture in which CD56bright versus CD56dim, CD16 and maturation state help describe NK cells, while subsets should not be treated as fixed binary functional labels.

That matters for reading the question 'What does CD16 do?' CD16 is a receptor with an antibody-facing role, but its presence on a cell is also used as part of a marker panel. A marker can help identify a population without proving what that population is doing at a given moment. The inference is not that CD16 is meaningless; it is that a CD16-positive label is not the same as a functional test.

What lab readouts add—and what they do not prove

Functional NK-cell assays can look at more than marker presence. A methods article titled 'Functional Analysis of Human NK cells by Flow Cytometry' describes using CD107a to track degranulation after target-cell stimulation, including K562/target-cell stimulation, alongside cytokine readouts. Degranulation is the release of granules from inside the NK cell; CD107a appears on the surface as part of that process, so it is used as a readout of degranulation.

The important limit comes from the same source: the authors explicitly state that degranulation does not equal target-cell lysis. Lysis means the target cell is damaged or destroyed. So a flow-cytometry signal that indicates degranulation is not, by itself, proof that a target cell was killed.

Swipe or scroll to read the full table →

Readout What the named study or organisation reports What it does not settle
CD3-negative plus CD16/CD56 markers Mayo Clinic Laboratories uses these markers to identify and count NK/NKT subsets; the test page says the test is not for diagnosing or classifying NK malignancy It does not show whether a particular NK cell will kill a target
CD107a after target-cell stimulation The flow-cytometry methods article uses CD107a to track degranulation after K562/target stimulation, with cytokine readouts Degranulation is not the same as target-cell lysis, as the authors state
CD57 within CD56dimCD16+ NK cells The human-cell study identifies CD57 as marking a functionally distinct mature population within that subset A subset label is not a fixed binary functional label, and CD16 alone does not define one behavior

The takeaway for reading 'CD16 NK cells'

CD16 gives NK cells an antibody-facing recognition route. When antibodies have marked a target, CD16 is one way an NK cell can engage that target. But CD16 is also used as a marker in subset panels, and marker presence is not a measurement of killing. CD56 and CD57 help describe NK-cell populations and maturity states; CD107a can report degranulation; none of these readouts is a standalone proof of target-cell lysis.

That distinction keeps the biology useful. 'CD16 on NK cells' can mean a functional receptor in an antibody response, a marker in a lab panel, or both in the same cell—without the label alone settling what the cell is doing.

This is general educational information, not medical advice or a diagnosis.

Sources and further reading

Keep reading

Follow the next question.

The biology